MARKET

IBB

IBB

iShares Nasdaq Biotechnology ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

164.85
+1.32
+0.81%
Opening 13:35 01/22 EST
OPEN
162.63
PREV CLOSE
163.53
HIGH
164.96
LOW
162.59
VOLUME
772.47K
TURNOVER
--
52 WEEK HIGH
166.36
52 WEEK LOW
92.15
TOTAL ASSET
10.37B
YTD YIELD
0.08%
1D
5D
1M
3M
1Y
5Y
News
Performance
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21)
Benzinga · 6h ago
Sector Update: Health Care Stocks Down In Friday's Premarket Trade
MT Newswires · 9h ago
Gene editors raise equity as shares climb amid investor interest
In recent months gene editors have witnessed an outsized share price performance driven by seemingly everlasting investor interest. Actively managed ARK Genomic Revolution Multi-Sector ETF (ARKG) focused on genomics has
Seekingalpha · 20h ago
'Fast Money' Traders Share Their Picks That Should Do Well Under Biden
On CNBC's "Fast Money," Steve Grasso named Trinseo S.A. (NYSE: TSE), Westrock Co (NYSE: WRK) and Olin Corporation (NY
Benzinga · 1d ago
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 20)
Benzinga · 1d ago
The Biden portfolio
The stocks most likely to get a boost from the new administration. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman, and Steve Grasso.
CNBC.com · 1d ago
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 19)
Benzinga · 2d ago
Sector Update: Health Care Stocks Climb Premarket Wednesday
MT Newswires · 2d ago
More
No Data
Learn about the latest financial forecast of IBB. Analyze the recent business situations of iShares Nasdaq Biotechnology ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
08/31/2020
10 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-3.6936%
--
1-Week
-1.9739%
--
1-Month
-6.1662%
--
3-Month
-1.8936%
--
6-Month
11.9477%
--
YTD
8.0849%
--
1-Year
29.1046%
--
3-Year
5.3735%
--
5-Year
3.1086%
--
10-Year
17.0547%
--
Since Inception
7.3696%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Profile
Fund Name
iShares Nasdaq Biotechnology ETF
Risk
Low risk
Inception Date
2001-02-05
Benchmark
Dow Jones US Healthcare TR
Advisor Company
iShares
Custodian
State Street Bank & Trust Co
Manager
Team Managed